Palmoplantar pustular psoriasis induced by adalimumab: a case report and literature review-Reference-Cited by-同舟云学术

Palmoplantar pustular psoriasis induced by adalimumab: a case report and literature review

Published:2015-07 Issue:7 Volume:7 Page:717-720
ISSN:1750-743X
Container-title:Immunotherapy
language:en
Short-container-title:Immunotherapy

Author:

Ibis Nurdan¹,Hocaoglu Sehriban¹,Cebicci Mehtap Aykac¹,Sutbeyaz Serap Tomruk¹,Calis Havva Talay¹

Affiliation:

1. Physical Therapy & Rehabilitation Department, Kayseri Education & Research Hospital, Atatürk Avenue, No:78, 38010 Kayseri, Turkey

Abstract

TNF-α inhibitors (anti-TNF-α) are agents increasingly used in the treatment of rheumatic diseases resistant to classical disease-modifying treatment and they provide significant improvement of disease activity. However, these agents have many cutaneous side effects including psoriasis. Numerous reports of the induction or worsening of psoriasis in patients treated with TNF antagonists indicate that this is not a rare phenomenon. In this study, we present a patient with ankylosing spondylitis who developed palmoplantar pustular psoriasis after receiving anti-TNF-α therapy for 4 months.

Publisher

Future Medicine Ltd

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.futuremedicine.com/doi/pdf/10.2217/imt.15.45

Reference12 articles.

1. Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata

2. Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases

3. Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis

4. Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradoxical Psoriasis in Patients Receiving Therapy with Tumor Necrosis Factor Inhibitors: Potential Pathogenic Mechanisms and the Role of Genetic Factors;International Journal of Molecular Sciences;2024-06-27

2. Teriflunomide-Induced Palmoplantar Pustular Psoriasis: Case Report and Review of the Literature;Cureus;2023-08-02

3. Cutaneous Manifestations of Reactions to Biologics;Current Allergy and Asthma Reports;2018-02

4. Anti-tumor necrosis factor-induced palmoplantar psoriasis: Case series;Journal of Dermatology and Dermatologic Surgery;2018

5. Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders;Current Drug Safety;2017-07-10